v3.20.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
Revenues $ 16,575,395 $ 11,851,915
Revenues from related party 29,029,249
Total revenues 45,604,644 11,851,915
Cost of revenues 26,902,916 4,041,122
Gross profit 18,701,728 7,810,793
Operating expenses:    
Personnel 3,841,725 1,339,832
Marketing and promotion 369,577 292,477
General and administrative 8,886,086 10,052,731
Bad debts 44,539,820 150,000
Goodwill write-downs 2,662,669 1,331,785
Total operating expenses 60,299,877 13,166,825
Operating income (41,598,149) (5,356,032)
Non-operating income (expenses):    
Interest expense (12,718,952) (4,366,295)
Interest income 467,798 593,214
Loss on debt settlements, net (5,180) (4,133,481)
Loss on equity investments (30,334,503) (43,221)
Change in fair value of investments (640,856)
Other 2,948,917 (2,858)
Total non-operating expenses, net (40,282,776) (7,952,641)
Net income (loss) (81,880,925) (13,308,673)
Net income (loss) attributable to noncontrolling interests (696,206) 295,395
Net income (loss) attributable to MariMed Inc. $ (81,184,719) $ (13,604,068)
Net income (loss) per share $ (0.39) $ (0.07)
Weighted average common shares outstanding 208,720,496 192,376,020

Source